CAESAREA, Israel–(BUSINESS WIRE)–Mazor Robotics Ltd (TASE: MZOR), the pioneer in innovative surgical
robots and complementary products for spine surgery, announced that its
clinically proven technology has been used to guide placement of more than
15,000 spinal implants, from routine to the most complex cases. Furthermore, in
thousands of surgeries worldwide with Mazor Robotics systems there have been no
reported cases of permanent nerve damage. This contrasts sharply to the current
standard of care.
Mazor Robotics has developed the world’s only robotic
systems that provide surgical guidance for spine surgeries. According to
published clinical data, Mazor Robotics technology has been scientifically
proven to increase the accuracy of spinal implants and significantly lower
rates of misplaced screws and neurological deficits. For patients, this means
fewer complications and revisions. More importantly, higher accuracy rates
means that more people are able to live with less pain and debilitation, a
reality made possible through the combination of Mazor Robotics unique
technology and the skill of the surgeons who use the system.
Following the success of its initial SpineAssist®, Mazor
Robotics recently introduced Renaissance™, its next generation system, which is
both FDA cleared and CE marked. Renaissance™ is transforming spine surgeries
from freehand procedures to highly accurate, state-of-the-art procedures, with
less radiation – even for minimally invasive surgery, scoliosis, and other
complex spinal deformity cases.
Spine surgeon Nitin N. Bhatia, MD, Irvine, California,
summarized the clinical advantages, remarking that Mazor Robotics technology
“saves on time, saves on radiation and the accuracy has been phenomenal.”
Dennis P. Devito, MD, a scoliosis specialist from Atlanta, Georgia,
recently reported clinical accuracy of 99.7% for 1,815 implants placed with
Mazor Robotics system in 120 scoliotic adolescents. According to current
scientific literature, the average accuracy is approximately 85-90% for
free-hand surgical techniques. Devito said, “I find it provides better patient
care through enhancement of the surgeons capabilities and it also makes my
surgical work easier.”
Ori Hadomi, CEO of Mazor Robotics, said, “This
clinical-success milestone is rewarding for our team and the leading spine
surgeons with whom we partner. It is so fulfilling to see our robotic
technology integrated in surgical practice in medical centers worldwide. The
most gratifying part of all is the enthusiasm from surgeons using Mazor
Robotics systems, reflecting their patients satisfaction with the outcome of
their spine surgeries. We look forward to more in-depth collaboration with
surgeons using our systems.”
About Mazor Robotics
Mazor Robotics Ltd (TASE:MZOR) is dedicated to the development and marketing of
innovative surgical robots and complementary products that provide a safer
surgical environment for patients, surgeons, and OR staff. Mazor Robotics
flagship product, Renaissance™, is a state-of-the-art surgical guidance system
that enables surgeons to conduct spine surgeries in an accurate and secure
manner. Mazor Robotics systems have been successfully used in the placement of
over 15,000 implants in the USA
and Europe. Numerous peer-reviewed
publications and presentations at leading scientific conferences have validated
the accuracy, usability, and clinical advantages of Mazor Robotics technology.
For more information, visit www.MazorRobotics.com
